eMedicine Specialties > Emergency Medicine > Toxicology

Toxicity, Hydrocarbons

Author: Michael D Levine, MD, Physician, Department of Medical Toxicology, Banner Good Samaritan Medical Center
Coauthor(s): Chip Gresham III, MD, Fellow, Department of Medical Toxicology, Banner Good Samaritan Medical Center, Phoenix Children's Hospital; Attending Physician, Department of Emergency Medicine, Arizona Heart Hospital
Contributor Information and Disclosures

Updated: Apr 30, 2009

Introduction

Background

Hydrocarbons are a heterogenous group of organic substances that are primarily composed of carbon and hydrogen molecules. They are quite abundant in modern society. Some of the most commonly ingested hydrocarbons include gasoline, lubricating oil, motor oil, mineral spirits, lighter fluid/naphtha, lamp oil, and kerosene.1  Other common sources of hydrocarbons include dry cleaning solutions, paint, spot remover, rubber cement, and solvents. In addition, many volatile substances that contain hydrocarbons (eg, glue, propellants) are commonly abused for their euphoric effects.

Hydrocarbons can be classified as being aliphatic, in which the carbon moieties are arranged in a linear or branched chain, or aromatic, in which the carbon moieties are arranged in a ring. Halogenated hydrocarbons are a subgroup of aromatic hydrocarbons, in which one of the hydrogen molecules is substituted by a halogen group. The most important halogenated hydrocarbons include carbon tetrachloride, trichloroethylene, tetrachloroethylene, trichloroethane, chloroform, and methylene chloride.  

The hydrocarbons can be derived from either petroleum or wood. Petroleum distillates include kerosene, gasoline, and naphtha, whereas wood-derived hydrocarbons include turpentine and pine oil. The length of the chains as well as the degree of branching determine the phase of the hydrocarbon at room temperature; most are liquid, but some short-chain hydrocarbons (eg, butane) are gas at room temperature, whereas other long-chain hydrocarbons (eg, waxes) are solid at room temperature.

Toxicity from hydrocarbon ingestion can affect many different organs, but the lungs are the most commonly affected organ. The chemical properties of the individual hydrocarbon determine the specific toxicity, while the dose and route of ingestion affect which organs are exposed to the toxicity. Unlike the aromatic or aliphatic hydrocarbons, the halogenated hydrocarbons tend to cause a wider range of toxicity.

The recreational use of inhaling hydrocarbons and other volatile solvents for the purposes of creating a euphoric state is becoming increasingly common. Several methods are used for this abuse, including "sniffing" (directly inhaling vapors), "huffing" (placing a hydrocarbon-saturated rag over the mouth and nose and then inhaling), or "bagging" (inhaling via a plastic bag filled with hydrocarbon vapors).

Pathophysiology

The toxicity of hydrocarbons is directly related to their physical properties, specifically the viscosity, volatility, surface tension, and chemical activity of the side chains. The viscosity is a measure of resistance to flow and is measured in Saybolt Seconds Universal (SSU). Substances with a lower viscosity (SSU <60, eg, turpentine, gasoline, naphtha) are associated with a higher chance of aspiration. The surface tension is a cohesive force created by van der Waals forces between molecules and is a measure of a liquid's ability to "creep." Like the viscosity, the surface tension is also inversely related to aspiration risk; the lower the viscosity, the higher the risk of aspiration. The viscosity is the single most important chemical property associated with the aspiration risk.2

Volatility is the tendency for a liquid to change phases and become a gas. Hydrocarbons with a high volatility can vaporize and displace oxygen, which can lead to a transient state of hypoxia. Not surprisingly, the degree of volatility is directly related with the risk of aspiration. The amount of hydrocarbon ingested has not consistently been linked to the degree of aspiration and hence pulmonary toxicity.

Toxicity from hydrocarbon exposure can be thought of as different syndromes, depending on which organ system is predominately involved. Organ systems that can be affected by hydrocarbons include the pulmonary, neurologic, cardiac, gastrointestinal, hepatic, renal, dermatologic, and hematologic systems. The pulmonary system is the most commonly involved system.3

Pulmonary

Pulmonary complications, especially aspiration, are the most frequently reported adverse effect of hydrocarbon exposure. While most aliphatic hydrocarbons have little GI absorption, aspiration frequently occurs, either initially or in a semidelayed fashion as the patient coughs or vomits, thereby resulting in pulmonary effects. Once aspirated, the hydrocarbons can create a severe pneumonitis.

Hydrocarbon pneumonitis results from a direct toxic affect by the hydrocarbon on the lung parenchyma. The type II pneumocytes are most affected, resulting in decreased surfactant production. This decrease in surfactant, results in alveolar collapse, ventilation-perfusion mismatch, and hypoxemia. Hemorrhagic alveolitis can subsequently occur, which peaks 3 days after ingestion.4 The end result of hydrocarbon aspiration is interstitial inflammation, intra-alveolar hemorrhage and edema, hyperemia, bronchial necrosis, and vascular necrosis.  Rare pulmonary complications include the development a pneumothorax, pneumatocele, or bronchopleural fistula.5

Nervous system

CNS toxicity can result from several mechanisms, including direct injury to the brain or indirectly as a result of severe hypoxia or simple asphyxiation.

Many of the hydrocarbons that affect the CNS directly can make their way across the blood-brain barrier because certain hydrocarbons are highly lipophilic. In addition, for individuals who are huffing or bagging, the act of rebreathing can result in hypercarbia, which can contribute to decreased level of arousal.

Prolonged abuse of hydrocarbons can result in white matter degeneration (leukoencephalopathy) and atrophy.6 7  In addition, prolonged exposure to certain hydrocarbons (eg, n -hexane or methyl-n -butyl ketone [MnBK]) can result in peripheral neuropathy, blurred vision, sensory impairment, muscle atrophy, and parkinsonism.8

Cardiovascular

Exposure to hydrocarbons can result in cardiotoxicity.9

Most importantly, the myocardium becomes sensitized to the effects of catecholamines, which can predispose the patient to tachydysrhythmias, which can result in syncope or sudden death.

Gastrointestinal

Many of the hydrocarbons create a burning sensation because they are irritating to the GI mucosa. Vomiting has been reported in up to one third of all hydrocarbon exposures. 

Hepatic10

The chlorinated hydrocarbons, in particular carbon tetrachloride, are hepatotoxic. Usually, the hepatotoxicity results after the hydrocarbon undergoes phase I metabolism, thereby inducing free radical formation. These free radicals subsequently bond with hepatic macromolecules and ultimately cause lipid peroxidation. This metabolite creates a covalent bond with the hepatic macromolecules, thereby initiating lipid peroxidation.

The common histopathologic pattern is centrilobular (zone III) necrosis.

Liver function test results can be abnormal within 24 hours after ingestion, and clinically apparent jaundice can occur within 48-96 hours.

Methylene chloride, a hydrocarbon commonly found in paint remover, is metabolized via the P450 mixed function oxidase system in the liver to carbon monoxide (CO). Unlike other cases of CO exposure, with methylene chloride, CO formation can continue for a prolonged period of time.

Renal

Chronic exposure to toluene, an aromatic hydrocarbon, can result in a distal renal tubular acidosis and present with an anion gap acidosis. A patient may have chronic exposure either via an occupational environment or by repeated recreational inhalation.

Hematologic

Prolonged exposure to certain aromatic hydrocarbons (especially benzene) can lead to an increased risk of aplastic anemia, multiple myeloma, and acute myelogenous leukemia. In addition, hemolysis has been reported following the acute ingestion of various types of hydrocarbons.11

Frequency

United States

In 2007, 48,497 cases of hydrocarbon poisoning were reported to US poison control centers. Of these, more than 22,000 were in patients aged 19 years or younger.12

International

In developing nations, kerosene is implicated in approximately one third of pediatric poisonings.

Mortality/Morbidity

In 2007, 7 deaths due to hydrocarbons were reported to US poison control centers.12 However, several other deaths are classified as being due to "chemicals, cleaning substances, fumes/gases/vaporizers," and "pesticides." Thus, the true number is probably slightly higher. In addition, the poison control data are widely known to be an underestimate of the true incidence because of underreporting.

Age

Proportionately, more fatalities are associated with children younger than 5 years who often accidentally ingest hydrocarbons, and among adolescents, who are more likely to abuse volatile hydrocarbons.

Inhalant abuse is becoming increasingly common among adolescents. It is estimated that approximately 20% of students in middle school and high school have abused volatile substances.13

Clinical

History

In cases of suspected hydrocarbon intoxication, it is important to determine the agent ingested, the route of ingestion (eg, oral, dermal, inhalational) the amount of substance ingested, and the time of the ingestion. In addition, the history should include questions about co-ingestants, any vomiting or coughing prior to arrival, and any attempt to treat the patient prior to arrival.

  • Respiratory distress
    • The lung is the primary site of most common toxicity following hydrocarbon exposures. Pulmonary toxicity most often occurs following ingestion and subsequent aspiration of hydrocarbon. Respiratory symptoms (eg, coughing, gagging, choking) usually occur within 30 minutes of exposure but often can be delayed several hours.
    • Many patients develop a transient cough. A prolonged cough and hypoxia, however, is more concerning for aspiration. Lack of coughing does not exclude the possibility of aspiration.
  • Nervous system
    • The most common CNS symptoms include headache, lethargy, and decreased mental status. Nonspecific symptoms such as weakness and fatigue may also be reported.
    • Because many of the solvents are highly lipophilic, solvent abuse causes a transient euphoria.
    • With prolonged exposure to n -hexane, MnBK, and possibly toluene, an axonopathy can occur. This peripheral neuropathy usually begins in the extremities and then progresses more proximally.
  • Cardiovascular
    • The patient may complain of dyspnea or syncope.
    • In addition, because of sensitization of the myocardium to catecholamines, a relatively young and previously healthy patient can present in full cardiac arrest after being suddenly startled or following strenuous athletic events. A common scenario for the cardiac arrest patient is the teenager who is huffing, or bagging alone in a dark room, who then gets startled when a parent opens the door. This "sudden sniffing death syndrome" results in ventricular fibrillation or ventricular tachycardia, following a large catecholamine exposure to a myocardium that is already sensitized to the effects of the catecholamines. This syndrome is more common following exposure to the halogenated hydrocarbons, but it can occur following exposure to aromatic hydrocarbons as well.
  • Gastrointestinal
    • Nausea, vomiting, and sore throat are frequent but are relatively mild.
    • Local reactions such as a burning sensation in the mouth, pruritus, or a perioral rash are not uncommon and are usually mild.
    • Diarrhea, melena, and hematemesis are rare.

Physical

Prior to instituting the physical examination, the patient should be appropriately decontaminated, if indicated.

The physical examination should focus on the patient's airway, breathing, and circulation (ABCs).

Patients who are experiencing any respiratory compromise should be placed on supplemental oxygen. For those patients who are in severe respiratory distress, or who are too lethargic to be able to adequately protect their airway, advanced airway management may be required.

  • Respiratory
    • Coughing
    • Gagging
    • Choking
    • Tachypnea
    • Hemoptysis
    • Rales
    • Rhonchi
    • Wheezes
    • Hypoxia
    • Cyanosis
  • Cardiovascular
    • Tachycardia
    • Dysrhythmias
    • Hypotension
  • CNS
    • Headache
    • Ataxia
    • Weakness
    • Lethargy to coma
    • Seizures
  • GI - Nausea/vomiting
  • Dermal
    • Erythema
    • Blistering
    • Pain
    • Nasal dermatitis or perioral dermatitis (with chronic abuse)
    • Skin irritation (with single use) at an intravenous, intramuscular, or subcutaneous injection site

Causes

Hydrocarbon exposure can be divided into the following 4 broad categories:

  • Nonintentional nonoccupational exposure: Accidental ingestions are the most frequent type and commonly involve young children tasting a hydrocarbon. Typically, children do not drink large quantities, as hydrocarbons generally taste bad. Adults and older children occasionally consume a hydrocarbon if liquid is placed in an unlabeled can or bottle resulting in accidental ingestion.
  • Recreational exposure: Inhaling of hydrocarbons or other volatile solvents for the purpose of producing a transient state of euphoria is becoming more common. This pattern of use is most common in junior high and high-school aged children.
  • Occupational exposure: This type of exposure is most often industrial, where a worker has either a dermal exposure to the liquid or an inhalational exposure to the vapors.
  • Intentional: This type of exposure usually involves consuming a large amount of the hydrocarbon as an oral ingestion during a suicide attempt.

More on Toxicity, Hydrocarbons

Overview: Toxicity, Hydrocarbons
Differential Diagnoses & Workup: Toxicity, Hydrocarbons
Treatment & Medication: Toxicity, Hydrocarbons
Follow-up: Toxicity, Hydrocarbons
Multimedia: Toxicity, Hydrocarbons
References

References

  1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green J, Rumack BH, Heard SE. 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol (Phila). Dec 2007;45(8):815-917. [Medline].

  2. Seymour FK, Henry JA. Assessment and management of acute poisoning by petroleum products. Hum Exp Toxicol. Nov 2001;20(11):551-62. [Medline].

  3. Lifshitz M, Sofer S, Gorodischer R. Hydrocarbon poisoning in children: a 5-year retrospective study. Wilderness Environ Med. 2003;14(2):78-82. [Medline].

  4. Gross P, McNerney JM, Babyak MA. Kerosene pneumonitis: an experimental study with small doses. Am Rev Respir Dis. Nov 1963;88:656-63. [Medline].

  5. Rodricks A, Satyanarayana M, D'Souza GA, Ramachandran P. Turpentine-induced chemical pneumonitis with broncho-pleural fistula. J Assoc Physicians India. Jul 2003;51:729-30. [Medline].

  6. Borne J, Riascos R, Cuellar H, Vargas D, Rojas R. Neuroimaging in drug and substance abuse part II: opioids and solvents. Top Magn Reson Imaging. Jun 2005;16(3):239-45. [Medline].

  7. Filley CM, Halliday W, Kleinschmidt-DeMasters BK. The effects of toluene on the central nervous system. J Neuropathol Exp Neurol. Jan 2004;63(1):1-12. [Medline].

  8. Garrettson LK. n-Hexane and 2-Hexanone. In: Sullivan JB, Krieger GR, eds. Clinical Environmental Health and Toxic Exposure. 2nd ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2001:1211-14; chap110.

  9. Klein BL, Simon JE. Hydrocarbon poisonings. Pediatr Clin North Am. Apr 1986;33(2):411-9. [Medline].

  10. Palmer RB, Phillips SD. Chlorinated hydrocarbons. In: Shannon MW, Borron SW, Burns MJ, eds. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. 4th ed. Philadelphia, Pa: Saunders; 2007:1347-61.

  11. Algren JT, Rodgers GC Jr. Intravascular hemolysis associated with hydrocarbon poisoning. Pediatr Emerg Care. Feb 1992;8(1):34-5. [Medline].

  12. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE. 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila). Dec 2008;46(10):927-1057. [Medline][Full Text].

  13. Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician. Sep 1 2003;68(5):869-74. [Medline].

Further Reading

Keywords

hydrocarbon toxicity, hydrocarbon poisoning, hydrocarbon exposure, hydrocarbon, hydrocarbon ingestion, inhaling hydrocarbons, hydrocarbon inhalation, halogenated hydrocarbons, carbon tetrachloride, trichloroethylene, tetrachloroethylene, trichloroethane, chloroform, methylene chloride, kerosene, gasoline, naphtha, wood-derived hydrocarbons, turpentine, pine oil, petroleum distillates, short-chain hydrocarbons, butane, long-chain hydrocarbons

Contributor Information and Disclosures

Author

Michael D Levine, MD, Physician, Department of Medical Toxicology, Banner Good Samaritan Medical Center
Michael D Levine, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American College of Medical Toxicology, American Medical Association, Emergency Medicine Residents Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Chip Gresham III, MD, Fellow, Department of Medical Toxicology, Banner Good Samaritan Medical Center, Phoenix Children's Hospital; Attending Physician, Department of Emergency Medicine, Arizona Heart Hospital
Chip Gresham III, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Medical Toxicology, Emergency Medicine Residents Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

David A Peak, MD, Assistant Residency Director of Harvard Affiliated Emergency Medicine Residency, Attending Physician, Massachusetts General Hospital; Consulting Staff, Department of Hyperbaric Medicine, Massachusetts Eye and Ear Infirmary
David A Peak, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Society for Academic Emergency Medicine, and Undersea and Hyperbaric Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

John T VanDeVoort, PharmD, Regional Director of Pharmacy, Sacred Heart & St. Joseph's Hospitals
John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists
Disclosure: Nothing to disclose.

Managing Editor

John G Benitez, MD, MPH, FACMT, FACPM, FAAEM, Associate Professor, Department of Medicine, Clinical Pharmacology Division, Vanderbilt University; Managing Director, Tennessee Poison Center
John G Benitez, MD, MPH, FACMT, FACPM, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Medical Toxicology, American College of Preventive Medicine, Society for Academic Emergency Medicine, Undersea and Hyperbaric Medical Society, and Wilderness Medical Society
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD, Assistant Professor, Department of Surgery, Section of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.